[go: up one dir, main page]

AR011094A1 - MEDICINAL PRODUCT CONTAINING TRIPLE COMBINATION QUINOXALINS AND THE USE OF QUINOXALINES IN TRIPLE COMBINATION WITH PROTEASE INHIBITORS AND TRANSCRIPTASE INHIBITORS AS A MEDICATION FOR THE TREATMENT OF AIDS AND / OR HIV INFECTIONS - Google Patents

MEDICINAL PRODUCT CONTAINING TRIPLE COMBINATION QUINOXALINS AND THE USE OF QUINOXALINES IN TRIPLE COMBINATION WITH PROTEASE INHIBITORS AND TRANSCRIPTASE INHIBITORS AS A MEDICATION FOR THE TREATMENT OF AIDS AND / OR HIV INFECTIONS

Info

Publication number
AR011094A1
AR011094A1 ARP980100377A ARP980100377A AR011094A1 AR 011094 A1 AR011094 A1 AR 011094A1 AR P980100377 A ARP980100377 A AR P980100377A AR P980100377 A ARP980100377 A AR P980100377A AR 011094 A1 AR011094 A1 AR 011094A1
Authority
AR
Argentina
Prior art keywords
triple combination
quinoxalines
inhibitors
aids
treatment
Prior art date
Application number
ARP980100377A
Other languages
Spanish (es)
Original Assignee
Mariani Mario
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mariani Mario filed Critical Mariani Mario
Publication of AR011094A1 publication Critical patent/AR011094A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Medicamento que contiene quinoxalinas en triple combinacion con inhibidores de proteasas e inhibidores de transcriptasa inversa, de formula(I), así como sus formas tautomeras de formula general (Ia), en donde R1, R2, R3, R4 y R5 tienenlos significados dados en las descripcion, son utiles, comomedicamento para el tratamiento del SIDA y/o de infecciones por HIV. También se refiere al uso de las quinoxalinas, de los inhibidores de proteasas y de losinhibidores de transcriptasa inversa, para la produccion de medicamentos para la terapia de infecciones por HIV.A drug containing quinoxalines in triple combination with protease inhibitors and reverse transcriptase inhibitors, of formula (I), as well as their tautomeric forms of general formula (Ia), where R1, R2, R3, R4 and R5 have the meanings given in The descriptions are useful as a medicine for the treatment of AIDS and / or HIV infections. It also refers to the use of quinoxalines, protease inhibitors, and reverse transcriptase inhibitors, for the production of drugs for the therapy of HIV infections.

ARP980100377A 1997-01-29 1998-01-28 MEDICINAL PRODUCT CONTAINING TRIPLE COMBINATION QUINOXALINS AND THE USE OF QUINOXALINES IN TRIPLE COMBINATION WITH PROTEASE INHIBITORS AND TRANSCRIPTASE INHIBITORS AS A MEDICATION FOR THE TREATMENT OF AIDS AND / OR HIV INFECTIONS AR011094A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19703131A DE19703131A1 (en) 1997-01-29 1997-01-29 Use of quinoxaline in a combination of three with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of AIDS and / or HIV infections

Publications (1)

Publication Number Publication Date
AR011094A1 true AR011094A1 (en) 2000-08-02

Family

ID=7818634

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980100377A AR011094A1 (en) 1997-01-29 1998-01-28 MEDICINAL PRODUCT CONTAINING TRIPLE COMBINATION QUINOXALINS AND THE USE OF QUINOXALINES IN TRIPLE COMBINATION WITH PROTEASE INHIBITORS AND TRANSCRIPTASE INHIBITORS AS A MEDICATION FOR THE TREATMENT OF AIDS AND / OR HIV INFECTIONS

Country Status (16)

Country Link
EP (1) EP0977570A1 (en)
JP (1) JP2001511124A (en)
KR (1) KR20000070543A (en)
CN (1) CN1251525A (en)
AR (1) AR011094A1 (en)
AU (1) AU6094098A (en)
BR (1) BR9807523A (en)
CA (1) CA2278773A1 (en)
DE (1) DE19703131A1 (en)
ID (1) ID22414A (en)
IL (1) IL130877A0 (en)
NO (1) NO993670L (en)
PL (1) PL334770A1 (en)
SK (1) SK99899A3 (en)
WO (1) WO1998032442A1 (en)
ZA (1) ZA98679B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
CA2374198A1 (en) * 1998-05-29 1999-12-02 Maki Arai Combination therapy for treatment of fiv infection
GB9821000D0 (en) * 1998-09-28 1998-11-18 Glaxo Group Ltd Antiviral combinations
AU6329599A (en) * 1998-09-28 2000-04-17 Glaxo Group Limited Antiviral combinations comprising (s)-2-ethyl -7-fluoro -3-oxo-3, 4-dihydro -2h-quinoxaline -1-carboxylic acid isopropyl ester
GB9911887D0 (en) * 1999-05-21 1999-07-21 Glaxo Group Ltd Methods and medicaments for post exposure prophylaxis of an hiv infection
SE9902987D0 (en) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
CO5300399A1 (en) 2000-02-25 2003-07-31 Astrazeneca Ab HETEROCICLIOCS CONTAINING NITROGEN, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR028948A1 (en) 2000-06-20 2003-05-28 Astrazeneca Ab NEW COMPOUNDS
US7005439B2 (en) 2000-06-20 2006-02-28 Astrazeneca Ab Compounds
GB0104050D0 (en) 2001-02-19 2001-04-04 Astrazeneca Ab Chemical compounds
AR035230A1 (en) 2001-03-19 2004-05-05 Astrazeneca Ab BENCIMIDAZOL COMPOUNDS, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION, AND USES OF THESE COMPOUNDS FOR THE PREPARATION OF MEDICINES
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
SE0101038D0 (en) 2001-03-23 2001-03-23 Astrazeneca Ab Novel compounds
SE0103818D0 (en) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (en) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
CA2633400A1 (en) * 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl urea for treating virus infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE205837T1 (en) * 1991-04-15 2001-10-15 Aventis Pharma Gmbh CHINOXALINES, PROCESS FOR THEIR PRODUCTION AND THEIR USE
DE4342024A1 (en) * 1993-12-09 1995-06-14 Hoechst Ag Combination preparations containing a quinoxaline and a nucleoside
DE19506742A1 (en) * 1995-02-27 1996-08-29 Bayer Ag Use of quinoxalines in combination with protease inhibitors as medicaments for the treatment of AIDS and / or HIV infections

Also Published As

Publication number Publication date
DE19703131A1 (en) 1998-07-30
ZA98679B (en) 1998-08-05
CN1251525A (en) 2000-04-26
NO993670D0 (en) 1999-07-28
EP0977570A1 (en) 2000-02-09
NO993670L (en) 1999-09-10
JP2001511124A (en) 2001-08-07
IL130877A0 (en) 2001-01-28
AU6094098A (en) 1998-08-18
CA2278773A1 (en) 1998-07-30
KR20000070543A (en) 2000-11-25
SK99899A3 (en) 2000-03-13
PL334770A1 (en) 2000-03-13
WO1998032442A1 (en) 1998-07-30
ID22414A (en) 1999-10-14
BR9807523A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
AR011094A1 (en) MEDICINAL PRODUCT CONTAINING TRIPLE COMBINATION QUINOXALINS AND THE USE OF QUINOXALINES IN TRIPLE COMBINATION WITH PROTEASE INHIBITORS AND TRANSCRIPTASE INHIBITORS AS A MEDICATION FOR THE TREATMENT OF AIDS AND / OR HIV INFECTIONS
UY28510A1 (en) CHEMICAL COMPOUNDS
ES2194501T3 (en) DERIVATIVES OF AMIDINAS, ITS PREPARATION, ITS APPLICATION AS DRUGS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
CU23105A3 (en) NOVEDOUS DERIVATIVES OF AMINODICARBOXILIC ACID WITH PHARMACEUTICAL PROPERTIES
ES2177868T3 (en) HYDROXYETHYLAMINOSULPHONAMIDS OF ALPHA- AND BETA-AMINO ACIDS AS INHIBITORS OF RETROVIRIC PROTEASES.
PA8432901A1 (en) PIRIDILPIRROL COMPOUNDS
ES2151906T3 (en) USE OF BACTERIA ENVELOPES OF THE ORDER OF THE BEGGIATOAL OR OF THE VITREOSCILLA GENDER AS ACTIVE INGREDIENT OF A MEDICINAL PRODUCT TO STIMULATE THE NON-SPECIFIC IMMUNITY.
UY27714A1 (en) 2 - HETEROARIL - CDK INHIBITING PYRIMIDINES, ITS PREPARATION AND ITS USE AS MEDICATIONS.
ES2153820T3 (en) DERIVATIVES OF BENZIMIDAZOL, PROCEDURE FOR PREPARATION AND APPLICATIONS.
AR033383A1 (en) ACRIDINE DERIVATIVES, PROCEDURE TO PREPARE THEM, THE USE OF THE SAME FOR THE PREPARATION OF MEDICINES AND THE MEDICINES CONTAINING THESE DERIVATIVES
ES2151908T3 (en) DERIVATIVES OF PHENYL-CYCLHEXAN-CARBOXYL ACID SUBSTITUTED WITH HETEROCICLO.
HUP0303082A2 (en) Substituted indoleoxoacetic piperazine derivatives, pharmaceutical compositions containing them and their antiviral use
DE60143911D1 (en) ANTITUMOR COMPOSITIONS CONTAINING ECTEINASCIDINE 743
CO5640037A2 (en) DERIVATIVES OF QUINAZOLINE FOR THE TREATMENT OF CANCER
BR0210158A (en) Pyrazole derivatives as hiv reverse transcriptase inhibitors
UY28356A1 (en) DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATIONS OF THE SAME AND ITS USES
AR128066A1 (en) HETEROCYCLIC PYRIMIDINE COMPOUND AND METHOD OF PREPARATION AND MEDICAL USE THEREOF
NO20043792L (en) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
AR003923A1 (en) A MEDICINAL PRODUCT CONTAINING, IN COMBINATION, ONE OR MORE PROTEASE INHIBITORS AND ONE OR MORE QUINOXALIN DERIVATIVES
PA8525801A1 (en) PIRAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS TO MODULATE AND / OR INHIBIT THE ACTIVITY OF ERAB / HADH2
AR003438A1 (en) AMINOME METLROMANES REPLACED BY BENZOISOTIAZOLYL, PROCEDURE FOR THEIR PRODUCTION, MEDICINES CONTAINING THEM, PROCEDURE FOR THE PRODUCTION OF THE MEDICINAL PRODUCTS, USE OF THEM FOR TREATMENT OF THE CENTRAL NERVOUS SYSTEM.
ES2054947T3 (en) ACIDOS 6-FLUORO-3,5-DIHIDROXICARBOXILICOS AND ITS DERIVATIVES, PROCEDURE FOR ITS PREPARATION, ITS USE AS MEDICATION, PHARMACEUTICAL PREPARATION AND INTERMEDIATE PRODUCT.
ES2101747T3 (en) PENCICLOVIR AND FAMCICLOVIR AND RELATED GUANINE DERIVATIVES FOR THE TREATMENT OF HIV-1 INFECTIONS.
ES2144857T3 (en) USE OF BENZONAPHTHALENIC DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT OF DISEASES OF THE NERVOUS SYSTEM.
PE20030236A1 (en) DERIVATIVES OF BENZIMIDAZOLE 1-ARIL-2-N, S- OR O-SUBSTITUTES, OBTAINING DRUGS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES